This compound is a pharmaceutical intermediate specifically used in the manufacturing process of Aliskiren, a renin inhibitor. It features a complex structure with multiple ether groups and a chiral center, which is critical for its role in the synthesis of the active pharmaceutical ingredient.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 866030-35-5
Trans-1,4-Dibromo-2-Butene
Aliskiren intermediate
2-(Chloromethyl)-4-methoxy-3-methylpyridine--hydrogen chloride (1/1)
Pharmaceutical intermediate synthesis
2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine Hydrochloride
Pharmaceutical intermediate
4-nitro-2,3,5-trimethylpyridine, 1-oxide
Pharmaceutical intermediate
Tert-Butyl 4-[6-[[6-(1-Butoxyethenyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-yl]amino]-pyridin-3-yl]-piperazine-1-carboxylate
pharmaceutical intermediate
(3S,5S)-5-((1S,3S)-1-Amino-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4-methylpentyl)-3-isopropyldihydrofuran-2(3H)-one
Active pharmaceutical ingredient intermediate impurity
tert-butyl N-[(1S,3S)-3-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-4-methyl-1-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]pentyl]carbamate
CYUJPKOZIGBPOO-IGRGDXOOSA-N
CC(C)[C@@H]1C[C@H](OC1=O)[C@H](C[C@H](CC2=CC(=C(C=C2)OC)OCCCOC)C(C)C)NC(=O)OC(C)(C)C